Cargando…
Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening cytokine storm syndrome. There are no definitive guidelines for the management of secondary HLH (sHLH). A recent report by a National Health Service (NHS) clinical panel has recommended anakinra as a treatment option. We aimed to analyse...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572845/ https://www.ncbi.nlm.nih.gov/pubmed/36233667 http://dx.doi.org/10.3390/jcm11195799 |
_version_ | 1784810718544003072 |
---|---|
author | Baverez, Clara Grall, Maximilien Gerfaud-Valentin, Mathieu De Gail, Sarah Belot, Alexandre Perpoint, Thomas Weber, Emmanuelle Reynaud, Quitterie Sève, Pascal Jamilloux, Yvan |
author_facet | Baverez, Clara Grall, Maximilien Gerfaud-Valentin, Mathieu De Gail, Sarah Belot, Alexandre Perpoint, Thomas Weber, Emmanuelle Reynaud, Quitterie Sève, Pascal Jamilloux, Yvan |
author_sort | Baverez, Clara |
collection | PubMed |
description | Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening cytokine storm syndrome. There are no definitive guidelines for the management of secondary HLH (sHLH). A recent report by a National Health Service (NHS) clinical panel has recommended anakinra as a treatment option. We aimed to analyse the efficacy and safety of anakinra for the treatment of all-cause sHLH. We conducted a multicentric retrospective study in two French University hospitals and included all patients who had a diagnosis of sHLH and who received anakinra. Among 21 patients (median age, 45 years), 13 were men. Anakinra was used as first-line therapy in 10 patients, and as monotherapy in 5 patients. We found that anakinra was effective in 19/21 patients (90.5%), with fever resolution in 19 patients (90.5%) within a median of 1.0 day (1, 2). At the Day 7 assessment, the mean CRP concentration decreased significantly (p < 0.001), as did the mean ferritin (p = 0.011). Anakinra was generally safe and well tolerated and was discontinued for side effects in only three patients (14.3%). Anakinra is an efficient and safe treatment to control sHLH of various causes. These data, together with the recent report of the NHS panel, call for the rapid conduct of prospective randomized clinical trials. |
format | Online Article Text |
id | pubmed-9572845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95728452022-10-17 Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases Baverez, Clara Grall, Maximilien Gerfaud-Valentin, Mathieu De Gail, Sarah Belot, Alexandre Perpoint, Thomas Weber, Emmanuelle Reynaud, Quitterie Sève, Pascal Jamilloux, Yvan J Clin Med Article Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening cytokine storm syndrome. There are no definitive guidelines for the management of secondary HLH (sHLH). A recent report by a National Health Service (NHS) clinical panel has recommended anakinra as a treatment option. We aimed to analyse the efficacy and safety of anakinra for the treatment of all-cause sHLH. We conducted a multicentric retrospective study in two French University hospitals and included all patients who had a diagnosis of sHLH and who received anakinra. Among 21 patients (median age, 45 years), 13 were men. Anakinra was used as first-line therapy in 10 patients, and as monotherapy in 5 patients. We found that anakinra was effective in 19/21 patients (90.5%), with fever resolution in 19 patients (90.5%) within a median of 1.0 day (1, 2). At the Day 7 assessment, the mean CRP concentration decreased significantly (p < 0.001), as did the mean ferritin (p = 0.011). Anakinra was generally safe and well tolerated and was discontinued for side effects in only three patients (14.3%). Anakinra is an efficient and safe treatment to control sHLH of various causes. These data, together with the recent report of the NHS panel, call for the rapid conduct of prospective randomized clinical trials. MDPI 2022-09-30 /pmc/articles/PMC9572845/ /pubmed/36233667 http://dx.doi.org/10.3390/jcm11195799 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Baverez, Clara Grall, Maximilien Gerfaud-Valentin, Mathieu De Gail, Sarah Belot, Alexandre Perpoint, Thomas Weber, Emmanuelle Reynaud, Quitterie Sève, Pascal Jamilloux, Yvan Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases |
title | Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases |
title_full | Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases |
title_fullStr | Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases |
title_full_unstemmed | Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases |
title_short | Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases |
title_sort | anakinra for the treatment of hemophagocytic lymphohistiocytosis: 21 cases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572845/ https://www.ncbi.nlm.nih.gov/pubmed/36233667 http://dx.doi.org/10.3390/jcm11195799 |
work_keys_str_mv | AT baverezclara anakinraforthetreatmentofhemophagocyticlymphohistiocytosis21cases AT grallmaximilien anakinraforthetreatmentofhemophagocyticlymphohistiocytosis21cases AT gerfaudvalentinmathieu anakinraforthetreatmentofhemophagocyticlymphohistiocytosis21cases AT degailsarah anakinraforthetreatmentofhemophagocyticlymphohistiocytosis21cases AT belotalexandre anakinraforthetreatmentofhemophagocyticlymphohistiocytosis21cases AT perpointthomas anakinraforthetreatmentofhemophagocyticlymphohistiocytosis21cases AT weberemmanuelle anakinraforthetreatmentofhemophagocyticlymphohistiocytosis21cases AT reynaudquitterie anakinraforthetreatmentofhemophagocyticlymphohistiocytosis21cases AT sevepascal anakinraforthetreatmentofhemophagocyticlymphohistiocytosis21cases AT jamillouxyvan anakinraforthetreatmentofhemophagocyticlymphohistiocytosis21cases |